4E22 image
Deposition Date 2012-03-07
Release Date 2012-12-19
Last Version Date 2024-02-28
Entry Detail
PDB ID:
4E22
Keywords:
Title:
Structure of cytidine monophosphate kinase from Yersinia pseudotuberculosis
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.32 Å
R-Value Free:
0.27
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
H 3
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Cytidylate kinase
Gene (Uniprot):cmk
Chain IDs:A
Chain Length:252
Number of Molecules:1
Biological Source:Yersinia pseudotuberculosis
Ligand Molecules
Primary Citation
Structure and function of cytidine monophosphate kinase from Yersinia pseudotuberculosis, essential for virulence but not for survival.
Open Biol 2 120142 120142 (2012)
PMID: 23271832 DOI: 10.1098/rsob.120142

Abstact

The need for new antibiotics has become pressing in light of the emergence of antibiotic-resistant strains of human pathogens. Yersinia pestis, the causative agent of plague, is a public health threat and also an agent of concern in biodefence. It is a recently emerged clonal derivative of the enteric pathogen Yersinia pseudotuberculosis. Previously, we developed a bioinformatic approach to identify proteins that may be suitable targets for antimicrobial therapy and in particular for the treatment of plague. One such target was cytidine monophosphate (CMP) kinase, which is an essential gene in some organisms. Previously, we had thought CMP kinase was essential for Y. pseudotuberculosis, but by modification of the mutagenesis approach, we report here the production and characterization of a Δcmk mutant. The isogenic mutant had a growth defect relative to the parental strain, and was highly attenuated in mice. We have also elucidated the structure of the CMP kinase to 2.32 Å, and identified three key residues in the active site that are essential for activity of the enzyme. These findings will have implications for the development of novel CMP kinase inhibitors for therapeutic use.

Legend

Protein

Chemical

Disease

Primary Citation of related structures